News

The foundation has a focus on promoting innovative research-based initiatives, including those addressing health issues. Lightlake has been developing a nasal spray for the delivery of naloxone that

Under the deal, Pfizer will acquire a portion of Baxter’s facility in Orth, Austria, and will also have access to Baxter’s meningitis vaccine, NeisVac-C, and its encephalitis vaccine,

The European approval applies to all European Union (EU) member states, as well as Iceland and Norway. In the EU, Eliquis is also approved to prevent venous thromboembolism

The project, funded by the PATH malaria vaccine initiative (MVI), will see Burnet use its new technology and ARTES’s patented Metavax platform for developing the new type of

The company’s PFS is designed as a low cost alternative to other auto-injectors in the market and it offers two single dose syringes of epinephrine, which is considered

The FDA clearance allows the company to start expanding its clinical investigation of PROHEMA into rare, non-malignant disorders. The company intends to start enrollment of the Phase Ib

Tanzeum is a once weekly option for patients, in combination with some other glucose-lowering medicines. In April 2014, the drug was approved by the US Food and Drug

Sunshine Biopharma anticipates that Sunshine Biopharma Canada will soon sign manufacturing, marketing, sales and distribution contracts for various pharmaceutical and biomedical products. According to various estimates, the worldwide

This operation, which will be realized in the coming weeks subject to the completion of certain usual conditions, is for Cellectis the extension to its strategic therapeutic focus.